My NCBI | Sign In
RSS Settings
  • Search: Knobil K[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 21

    1.

    Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes.

    Anzueto A, Ferguson GT, Feldman G, Chinsky K, Seibert A, Emmett A, Knobil K, O'Dell D, Kalberg C, Crater G.

    COPD. 2009 Oct;6(5):320-9.PMID: 19863361 [PubMed - in process]Related articles

    2.

    Adherence to inhaled therapy, mortality and hospital admission in COPD.

    Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW.

    Thorax. 2009 Nov;64(11):939-43. Epub 2009 Aug 23.PMID: 19703830 [PubMed - in process]Related articles

    3.

    Long-acting beta-agonists in asthma.

    Knobil K.

    N Engl J Med. 2009 Jul 9;361(2):208-9; author reply 209. No abstract available. PMID: 19593857 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lung function decline in COPD trials.

    Keene ON, Celli B, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.

    Eur Respir J. 2009 Mar;33(3):708-9; author reply 709-10. No abstract available. PMID: 19251815 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.

    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.

    Respir Med. 2008 Aug;102(8):1099-108. Epub 2008 Jul 9.PMID: 18614347 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.

    Bleecker ER, Emmett A, Crater G, Knobil K, Kalberg C.

    Pulm Pharmacol Ther. 2008 Aug;21(4):682-8. Epub 2008 May 1.PMID: 18541448 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.

    Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. Epub 2008 May 29.PMID: 18511702 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).

    Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R; ECLIPSE investigators.

    Eur Respir J. 2008 Apr;31(4):869-73. Epub 2008 Jan 23.PMID: 18216052 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The efficacy and safety of cilomilast in COPD.

    Rennard S, Knobil K, Rabe KF, Morris A, Schachter N, Locantore N, Canonica WG, Zhu Y, Barnhart F.

    Drugs. 2008;68 Suppl 2:3-57. doi: 10.2165/0003495-200868002-00002. Review.PMID: 19105585 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.

    O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K.

    Chest. 2006 Sep;130(3):647-56.PMID: 16963658 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Future perspectives in COPD.

    Celli B, Goldstein R, Jardim J, Knobil K.

    Respir Med. 2005 Dec;99 Suppl B:S41-8. Epub 2005 Oct 26. Review.PMID: 16256325 [PubMed - indexed for MEDLINE]Related articles

    12.

    The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.

    Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K.

    Clin Ther. 2005 May;27(5):531-42.PMID: 15978302 [PubMed - indexed for MEDLINE]Related articles

    13.

    The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.

    Hanania NA, Kalberg C, Yates J, Emmett A, Horstman D, Knobil K.

    Pulm Pharmacol Ther. 2005;18(1):19-22.PMID: 15607123 [PubMed - indexed for MEDLINE]Related articles

    14.

    A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

    Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

    Treat Respir Med. 2004;3(3):173-81.PMID: 15219176 [PubMed - indexed for MEDLINE]Related articles

    15.

    Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.

    Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P.

    Ann Allergy Asthma Immunol. 2002 Apr;88(4):401-9.PMID: 11991558 [PubMed - indexed for MEDLINE]Related articles

    16.

    Salmeterol plus theophylline combination therapy in the treatment of COPD.

    ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K.

    Chest. 2001 Jun;119(6):1661-70.PMID: 11399688 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.

    Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.

    J Allergy Clin Immunol. 2000 Dec;106(6):1088-95. Erratum in: J Allergy Clin Immunol 2001 Apr;107(4):614. PMID: 11112891 [PubMed - indexed for MEDLINE]Related articles

    18.

    Time to onset of effect of fluticasone propionate in patients with asthma.

    Szefler SJ, Boushey HA, Pearlman DS, Togias A, Liddle R, Furlong A, Shah T, Knobil K.

    J Allergy Clin Immunol. 1999 May;103(5 Pt 1):780-8.PMID: 10329810 [PubMed - indexed for MEDLINE]Related articles

    19.

    Role of oxidants in influenza virus-induced gene expression.

    Knobil K, Choi AM, Weigand GW, Jacoby DB.

    Am J Physiol. 1998 Jan;274(1 Pt 1):L134-42.PMID: 9458811 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation.

    Choi AM, Knobil K, Otterbein SL, Eastman DA, Jacoby DB.

    Am J Physiol. 1996 Sep;271(3 Pt 1):L383-91.PMID: 8843786 [PubMed - indexed for MEDLINE]Related articles

    21.

    Dyspnea in a patient years after severe poliomyelitis. The role of cardiopulmonary exercise testing.

    Knobil K, Becker FS, Harper P, Graf LB, Wolf GT, Martinez FJ.

    Chest. 1994 Mar;105(3):777-81.PMID: 8131540 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity